University Health Network
Toronto, Ontario, M5G 2C4, Canada
NCT Number: NCT00936416
Estimation of Glomerular Filtration Rate (GFR) is the primary test used to assess patients with renal disease. Although serum creatinine based GFR and nuclear medicine based estimations are routinely used in clinical practice, GFR estimation by Inulin is the recommended gold standard. Inulin based estimation of GFR is cumbersome and time consuming.
A decrease in blood flow to the kidney (Renal Blood Flow (RBF)) is known to cause a decrease in GFR. RBF is typically determined using radioactive tracers, contrast MRI or a cumbersome para-aminohippuric acid (PAH) clearance method.
MRI based assessment of GFR and RBF have been suggested to provide reasonable accuracy. Most of these studies did not compare the GFR and RBF estimation directly to Inulin and PAH clearance which are ther gold standards . In this study we propose to estimate MRI based GFR estimation directly to Inulin and noncontrast MRI based derived RBF to PAH to assess if MRI is an accurate test of kidney function.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M5G 2C4, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
GFR and renal blood flow estimation by Inulin and PAH clearance will be performed in the Renal Physiology Lab for approximately 2.5 hours;
The MRI test will be performed afterwards at Medical Imaging department and last about 45 minutes.
Time frame: 1 year
University Health Network, Toronto
Other
Assessment of Renal Physiology (Glomerular Filtration Rate and Blood Flow) by MRI With Validation by Inulin and Para-Aminohippuric Acid Clearance in Normal Volunteers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07441811
Adnexal Diseases, Cysts
Uşak, Turkey (Türkiye)
View Trial DetailsNCT06976281
Blood Flow Restriction Training, Glomerular Filtration Rate
Banī Suwayf, Egypt
View Trial DetailsNCT06765811
Chronic Disease, Chronic Kidney Disease
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04833231
Chronic Disease, Chronic Kidney Disease
Konya, Turkey (Türkiye)
View Trial Details